Projects funded by the NCN
New Hexokinase II inhibitors, in search of innovative therapeutic approaches to cancer treatment
2017/27/N/NZ7/01513
Keywords:
Hexokinase II inhibitors cancer treatment
Descriptors:
- NZ7_12: Prevention of human diseases
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_16: Other related subjects
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Politechnika Śląska, Wydział Chemiczny
woj. śląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 14 - announced on 2017-09-15
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2018-08-10
Project end date (Y-m-d): 2022-02-09
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.